Literature DB >> 7848492

Propofol anaesthesia in electroconvulsive therapy. Reduced seizure duration may not be relevant.

C F Fear1, C S Littlejohns, E Rouse, P McQuail.   

Abstract

BACKGROUND: The induction agent propofol is known to reduce electroconvulsive therapy (ECT) seizure duration. It is assumed that outcome from depression is adversely affected by this agent. This study compares propofol and methohexitone as induction agents for ECT.
METHOD: In a prospective, randomised, double-blind study 20 subjects with major depressive disorder (DSM-III-R criteria) received propofol or methohexitone anaesthesia. The Hamilton Depression Rating Scale and Beck Depression Inventory were used to assess depression before therapy, at every third treatment, and at the end of therapy. Seizure duration was measured using the cuff technique.
RESULTS: Mean seizure durations (P < 0.01) and mean total seizure duration (P < 0.01) were shorter in the propofol group. There was no difference in outcome.
CONCLUSIONS: Use of propofol may not adversely affect outcome from depression and it is not necessarily contraindicated as an induction agent for ECT. Our results should be interpreted cautiously, and larger studies are needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848492     DOI: 10.1192/bjp.165.4.506

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

Review 1.  [Anesthesia for electroconvulsive therapy].

Authors:  U Grundmann; S O Schneider
Journal:  Anaesthesist       Date:  2013-04       Impact factor: 1.041

Review 2.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression-The Results From the KEOpS Study.

Authors:  Jerome Brunelin; Sylvain Iceta; Marion Plaze; Raphaël Gaillard; Louis Simon; Marie-Françoise Suaud-Chagny; Filipe Galvao; Emmanuel Poulet
Journal:  Front Pharmacol       Date:  2020-09-15       Impact factor: 5.810

Review 4.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

Review 5.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 6.  Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression.

Authors:  Peng Lihua; Min Su; Wei Ke; Patrick Ziemann-Gimmel
Journal:  Cochrane Database Syst Rev       Date:  2014-04-11

7.  A comparison of propofol and thiopentone for electroconvulsive therapy.

Authors:  Alok Kumar; Devendra Kumar Sharma; Raghunandan Mani
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-07

8.  The Psychiatric Patient as a Health Resource Consumer: Costs Associated with Electroconvulsive Therapy.

Authors:  Carmen Selva-Sevilla; Maria Luisa Gonzalez-Moral; Maria Teresa Tolosa-Perez
Journal:  Front Psychol       Date:  2016-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.